Definition
With the advent of widespread use of ART and associated immunologic recovery and viral suppression, there has been a concomitant reduction in AIDS-related mortality across multiple patient populations worldwide. This phenomenon has led to the emergence of noncommunicable diseases, such as non-AIDS malignancies, hepatic disease, and cardiovascular disease as major sources of morbidity and mortality in the HIV-infected population. Included among these complications are cardiovascular diseases that affect the heart and peripheral vasculature. During the early course of the HIV epidemic, the major cardiovascular complications included dilated cardiomyopathy and pericarditis. While these are present in the current era of HIV treatment, the successes of antiretroviral therapy (ART) and the aging of the HIV-infected population combined with unique predisposing factors have led to the emergence of coronary heart disease (CHD) as a major source of morbidity and mortality. Management...
This is a preview of subscription content, log in via an institution to check access.
References
Aberg JA. Cardiovascular complications in HIV management: past, present, and future. J Acquir Immune Defic Syndr. 2009;50(1):54–64.
Boccara F, Lang S, Meuleman C, et al. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013;61(5):511–23.
Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141–55.
Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525–33.
Ding X, Andraca-Carrera E, Cooper C, et al. No association of abacavir use with myocardial infarction: findings of an FDA meta-analysis. J Acquir Immune Defic Syndr. 2012;61(4):441–7.
El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283–96.
Freiberg MS, Chang CC, Kuller LH, et al. HIV Infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013:1–9. doi:10.1001/jamainternmed.2013.3728.
Friis-Moller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356(17):1723–35.
Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352(1):48–62.
Grinspoon SK, Grunfeld C, Kotler DP, et al. State of the science conference: initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation. 2008;118(2):198–210.
Grunfeld C, Kotler DP, Arnett DK, et al. Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. Circulation. 2008;118(2):e20–8.
Hsue PY, Hunt PW, Schnell A, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. Aids. 2009;23(9):1059–67.
Schambelan M, Wilson PW, Yarasheski KE, et al. Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. Circulation. 2008;118(2):e48–53.
Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Suchindran, S., Triant, V.A. (2014). Cardiovascular Complications. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_176-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9610-6_176-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-9610-6
eBook Packages: Springer Reference MedicineReference Module Medicine